SPARK BIOMEDICAL INC.
Dallas, TX · Founded 2023 · CIK 0001975271 · Medtech · Private
Sparrow, a wearable transcutaneous auricular vagus nerve stimulation device for acute stress reaction
sparkbiomedical.com →- Grants
- $7.2M
- 9 awards
- Sector median: 1
- Raised
- $16M
- 1 Form D · May 2023
- 40 months since last filing
- Contracts
- $171K
- 1 award · Defense
- #470 of 4531 in medtech
- Patents
- 25
- 8 granted · 17 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓20192020202120222023202420252026
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | Department of Health and Human Services · Phase I · Transcutaneous auricular neurostimulation for neonatal abstinence syndrome | $217,690 | |
| Federal grant | Department of Health and Human Services · Phase II · Delivering Transcutaneous Auricular Neurostimulation to Improve Treatment Retention in Opioid Use Disorder | $1,246,700 | |
| Federal grant | Department of Health and Human Services · Phase II · Delivering Transcutaneous Auricular Neurostimulation as an Adjunct Treatment for Neonatal Opioid Withdrawal Syndrome | $1,249,662 | |
| Federal contract· 1 of 2 same day | Department of Defense · Medical Research And Development Contract Army STTR Ph I Proposal A21C-T024-0261 Titled A Wearable Transcutaneous Auricular Nerve Stimulation Device To Restore Performance After Acute Stress Reaction. | $171,429 | |
| Federal grant· 2 of 2 same day | Department of Defense · Phase I · A Wearable Transcutaneous Auricular Nerve Stimulation Device to Restore Performance after Acute Stress Reaction | $172,632 | |
| Federal grant | Department of Health and Human Services · Phase II · Delivering Transcutaneous Auricular Neurostimulation to Improve Treatment Retention in Opioid Use Disorder | $1,246,700 | |
| Federal grant | Department of Health and Human Services · Phase II · Delivering Transcutaneous Auricular Neurostimulation as an Adjunct Treatment for Neonatal Opioid Withdrawal Syndrome | $1,248,001 | |
| Private capital raised | Form D · SEC | $16,234,159 | |
| Federal grant | Department of Defense · Phase II · Development and Testing of a Military-Grade Wearable Transcutaneous Auricular Neurostimulation Device to Restore Performance after Acute Stress Reaction | $1,149,775 | |
| Federal grant | Department of Health and Human Services · Phase I · Development of a Machine Learning Algorithm to Detect Opioid Withdrawal and Cravings to Increase Treatment Retention | $318,875 | |
| Federal grant | Department of Health and Human Services · Phase I · Study of Transcutaneous Auricular Neurostimulation as a Treatment for Alcohol Use Disorder | $305,545 |
Federal grant · SBIR/STTRFederal contract · USAspendingForm D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 467 | TWINSTRAND BIOSCIENCES INC | $174K | $85M |
| 468 | ISCIENCE INTERVENTIONAL CORP | $174K | $24M |
| 469 | EVREN TECHNOLOGIES, INC. | $172K | — |
| 470 | SPARK BIOMEDICAL INC. | $171K | $16M |
| 471 | Assurex Health | $171K | — |
| 472 | Gold Standard Diagnostics Corp. | $167K | $2.5M |
| 473 | CMP Scientific Corp | $167K | $300K |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Ted CostopoulosDirector
- Alejandro CovalinDirector · Executive Officer
- Carl DeeleyDirector
- Navid KhodaparastDirector · Executive Officer
- Daniel PowellDirector · Executive Officer
Patents
- Improved Delivery Of Non-penetrating Electrical Neurostimulation Therapyapplication
- Neurostimulation Therapy For Treating Uterine Bleedinggranted
- Wearable Auricular Neurostimulator and Methods of Useapplication
- Neurostimulation Therapy For Treating Infertility Conditionsapplication
- Controlling Or Reducing Stress Using Auricular Neurostimulationapplication
- Devices And Methods For Treating Motion Sickness Using Electrical Stimulationapplication
- Delivery Of Non-penetrating Electrical Neurostimulation Therapygranted
- Electrical Stimulation Methods And Devices For Improving Blood Managementgranted
- Devices And Methods For Recovering From Brain Trauma Using Electrical Stimulationapplication
- Wearable Auricular Neurostimulator and Methods of Usegranted
- Controlling Or Reducing Stress Using Auricular Neurostimulationgranted
- Devices And Methods For Treating Motion Sickness Using Electrical Stimulationgranted
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.